Rachid Baz, MD, Director of Malignant Hematology Department in Moffitt Cancer Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Rachid Baz, MD

Rachid Baz, MD

Healthcare Professional
Director
Malignant Hematology Department
Moffitt Cancer Center
12902 USF Magnolia Drive
Tampa, Florida, United States
Dr. Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from the Cleveland Clinic. Currently, Dr. Baz is Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center. In addition, he is the Director of Clinical Research in the Malignant Hematology Department.
 
He received his medical degree from American University of Beirut. He completed his residencies in Internal Medicine and Hematology and Medical Oncology from Cleveland Clinic Foundation.
 
Dr. Baz has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom’s macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.
 
 
Representative Publications:
 
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close